Please ensure Javascript is enabled for purposes of website accessibility

johnson & johnson

People gather next to a logo of Johnson & Johnson at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, on Nov. 6, 2025. (REUTERS/Maxim Shemetov)
Dec 23, 2025

Baltimore jury hits Johnson & Johnson with record $1.5B talc cancer judgment

A Baltimore jury ordered Johnson & Johnson to pay over $1.5 billion to a woman who claimed its talc-based products caused her cancer.

Johnson's baby powder on display at a market in Pittsburgh, Jan. 26, 2023. (AP File Photo/Gene J. Puskar)
Dec 15, 2025

Johnson & Johnson ordered to pay $40M to two women in talc trial

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ovarian cancer.

This Feb. 24, 2021, photo shows a Johnson & Johnson logo on the exterior of a first aid kit in Walpole, Mass. The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law. The court ruled in a 5-1 decision Tuesday, Nov. 9, 2021, that the district court in 2019 was wrong to find that New Jersey-based J&J and its Belgium-based subsidiary Janssen Pharmaceuticals violated the state's public nuisance statute. (AP Photo/Steven Senne, File)
Feb 25, 2022

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis.

Md. AG Brian Frosh on initiatives, opinions and the upcoming legislative session
Jan 28, 2022

Most Md. subdivisions will participate in opioid settlement — but not Baltimore

Maryland and nearly all of its political subdivisions have agreed to participate in a financial settlement with Johnson & Johnson and several opioid distributors.

This Feb. 24, 2021, photo shows a Johnson & Johnson logo on the exterior of a first aid kit in Walpole, Mass. The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law. The court ruled in a 5-1 decision Tuesday, Nov. 9, 2021, that the district court in 2019 was wrong to find that New Jersey-based J&J and its Belgium-based subsidiary Janssen Pharmaceuticals violated the state's public nuisance statute. (AP Photo/Steven Senne, File)
Nov 9, 2021

$465M opioid ruling against Johnson & Johnson overturned

The Oklahoma Supreme Court overturned a $465M opioid ruling against Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law.

This photo provided by New Mexico State University shows Aggie Health and Wellness Center nurse Marissa Archuleta administering a Johnson & Johnson COVID-19 vaccine to Lauren Naranjo at a walk in clinic at Corbett Center in Las Cruces, New Mexico, on May 13, 2021. New Mexico's institutions of higher learning are spearheading efforts to vaccinate young people across the state. (Josh Bachman/New Mexico State University via AP)
Oct 5, 2021

J&J seeks clearance for COVID-19 vaccine booster doses

Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine.

Emergent BioSolutions is headquartered in Gaithersburg. (The Daily Record/File Photo)
Jul 29, 2021

FDA letting troubled COVID vaccine factory in Baltimore restart

The FDA is allowing the problem-plagued Baltimore factory of Emergent BioSolutions to resume production of the Johnson & Johnson COVID-19 vaccine.

The primary contributor to the majority of overdose deaths in Maryland involves some form of opioids. (Photo by Patrick Sison, AP)
Jun 28, 2021

Johnson & Johnson to pay $230M to settle New York opioid claim

Johnson & Johnson has agreed to pay $230 million to New York state to settle claims that the pharmaceutical giant helped fuel the opioid crisis.

Emergent BioSolutions is headquartered in Gaithersburg. (The Daily Record/File Photo)
Jun 23, 2021

Investor sues Emergent BioSolutions for alleged fraud, seeks class action

Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor […]

Aug 26, 2019

Okla. judge rules against drugmaker, orders $572M payment

NORMAN, Oklahoma — An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries helped fuel the state’s opioid crisis and ordered the consumer products giant to pay $572 […]

Theme park files lawsuit of biblical proportions
May 28, 2019

Theme park files lawsuit of biblical proportions

Welcome to Tuesday, the 45th anniversary of the Broadway premiere of “The Magic Show.” Here are some news items to get your work week started: — Noah’s Ark theme park […]

Judge won’t enjoin Md. from enforcing its drug price gouging law
May 9, 2018

Federal opioid judge demands litigation-funding deals for his review

The judge overseeing more than 600 lawsuits targeting opioid makers is demanding local governments' lawyers turn over any litigation-funding agreements so he can insure lenders have no control over the cases.

Networking Calendar

Submit an entry for the business calendar